Alligator Bioscience AB (FRA:7AL)

€ 0.0445 0.001 (2.3%) Market Cap: 36.64 Mil Enterprise Value: 33.37 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 42/100

Q3 2024 Alligator Bioscience AB Earnings Call Transcript
Oct 24, 2024

€0.0686 (-27.02%)

Earnings
Q2 2024 Alligator Bioscience AB Earnings Call Transcript
Jul 11, 2024

€0.0966 (+3.21%)

Earnings
Q4 2023 Alligator Bioscience AB Earnings Call Transcript
Feb 09, 2024

€0.0739 (-12.96%)

Earnings
Q2 2023 Alligator Bioscience AB Earnings Call Transcript
Jul 13, 2023

€0.036 (-0.28%)

Earnings
Q1 2023 Alligator Bioscience AB Earnings Call Transcript
Apr 25, 2023

€0.0527 (-8.95%)

Earnings
Q4 2022 Alligator Bioscience AB Earnings Call Transcript
Feb 10, 2023

€0.089583 (-14.13%)

Earnings
Q3 2022 Alligator Bioscience AB Earnings Call Transcript
Oct 20, 2022

€0.081227 (-1.49%)

Earnings
Alligator Bioscience AB at Redeye Growth Day (Virtual) Transcript
Jun 02, 2022
Q1 2022 Alligator Bioscience AB Earnings Call Transcript
Apr 27, 2022

€0.108262 (-2.22%)

Earnings
Q4 2021 Alligator Bioscience AB Earnings Call Transcript
Feb 11, 2022

€0.140089 (-1.51%)

Earnings
Q3 2021 Alligator Bioscience AB Earnings Call Transcript
Oct 22, 2021

€0.160409 (+7.24%)

Earnings
Q2 2021 Alligator Bioscience AB Earnings Call Transcript
Jul 13, 2021

€0.31968 (-0.53%)

Earnings
Q4 2020 Alligator Bioscience AB Earnings Call Transcript
Feb 26, 2021

€0.362988

Earnings
Alligator Bioscience AB at Biostock Life Science Summit (Virtual) Transcript
Nov 18, 2020
Q3 2020 Alligator Bioscience AB Earnings Call Transcript
Oct 22, 2020

€0.477916 (+7.32%)

Earnings
Alligator Bioscience AB R&D Market Update Transcript
Aug 27, 2020
Alligator Bioscience AB at AACR Virtual Annual Meeting Transcript
Apr 27, 2020
Q4 2019 Alligator Bioscience AB Earnings Call Transcript
Feb 12, 2020

€0.452501 (-1.68%)

Earnings

Q3 2021 Alligator Bioscience AB Earnings Call Transcript

Oct 22, 2021 / 12:00PM GMT

Release Date Price: €0.160409 (+7.24%)

Transcript

Operator

Hello and welcome to the Alligator Bioscience Q3 report 2021. (Operator Instructions) Today, I'm pleased to present Julie Silber, Senior Director of Investor Relations. Please go ahead with your meeting.

Julie Silber

Alligator Bioscience AB - Senior Director IR

Thank you. Hello, and welcome to Alligator Bioscience's third-quarter 2021 interim call. This is Julie Silber, Senior Director of Communications and Investor Relations, and I will be introducing today's call. On the call with me today is CEO, SÃ¸ren Bregenholt; and CFO, Marie Svensson. After a brief company statement by management, we will open up the call for Q&A.

Slide 2, please. Before we begin, I would like to share a quick reminder with our listeners that during today's call, management may make forward-looking statements that involve known and unknown risks, uncertainties, and other important factors beyond the company's control that could cause the company's actual results, performance or achievements to be materially different from that expected results, performance, and

Already have an account? Log in

Get the full story

Start 7-Day Free Trial

	Access to All Earning Calls and Stock Analysis
	30-Year Financial on one screen
	All-in-one Stock Screener with unlimited filters
	Customizable Stock Dashboard
	Real Time Insider Trading Transactions
	8,000+ Institutional investors’ 13F holdings
	Powerful Excel Add-in and Google sheets Add-on
	All data downloadable
	Quick customer support
	And much more...

30-Day 100% money back guarantee

You are not charged until the trial ends. Subscription fee may be tax deductible.

Excellent

4.6 out of 5

Trustpilot

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.